KRMD
KORU Medical Systems Inc.
$3.96
+$0.06(+1.54%)
35
Overall
40
Value
30
Tech
--
Quality
Market Cap
$187.25M
Volume
69.28K
52W Range
$1.86 - $5.05
Target Price
$5.60
Order:
Income Statement
| Metric | Trend | Chart | 2014 Feb | 2016 Feb | 2017 Feb | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $8.7M | $12.2M | $12.3M | $17.4M | $23.2M | $24.2M | $23.5M | $27.9M | $28.5M | $33.6M | ||
| Total Revenue | $8.7M | $12.2M | $12.3M | $17.4M | $23.2M | $24.2M | $23.5M | $27.9M | $28.5M | $33.6M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-3.4M | $-4.6M | $-4.7M | $-6.5M | $-8.3M | $9.2M | $9.7M | $12.5M | $11.8M | $12.3M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $5.3M | $7.6M | $7.6M | $10.8M | $14.9M | $14.9M | $13.8M | $15.4M | $16.7M | $21.3M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-4.3M | $-6.4M | $-8.3M | $-9.6M | $-14.3M | $16.2M | $20.8M | $26.1M | $27.0M | $27.8M | ||
| Research & Development | $218.2K | $207.3K | $237.5K | $241.1K | $740.5K | $1.3M | $2.5M | $5.0M | $5.7M | $5.3M | ||
| Research Expense | $218.2K | $207.3K | $237.5K | $241.1K | $740.5K | $1.3M | $2.5M | $5.0M | $5.7M | $5.3M | ||
| Selling, General & Administrative | $3.9M | $5.9M | $7.8M | $8.2M | $9.8M | $12.0M | $17.9M | $20.6M | $20.4M | $21.6M | ||
| Selling & Marketing Expenses | $3.9M | $5.9M | $7.8M | $8.2M | $9.8M | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | -- | $-132.5K | $-132.5K | $-132.5K | $-171.0K | $12.0M | $17.9M | $20.6M | $20.4M | $21.6M | ||
| Salaries & Wages | $-131.8K | -- | -- | -- | -- | -- | $2.7M | $3.1M | -- | -- | ||
| Depreciation & Amortization | $233.0K | $271.6K | $300.6K | $309.3K | $340.2K | $418.6K | $463.1K | $587.1K | $870.4K | $888.5K | ||
| Depreciation & Amortization | $233.0K | $271.6K | $300.6K | $309.3K | $340.2K | $418.6K | $463.1K | $587.1K | $870.4K | $888.5K | ||
| Amortization | $-131.8K | -- | -- | -- | $-4.8K | $5.3K | $2.6K | $50.9K | $110.6K | $181.2K | ||
| Other Operating Expenses | -- | -- | -- | -- | $-149.6K | $216.9K | $296.1K | $645.8K | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $1.0M | $1.2M | $-736.3K | $2.1M | $4.0M | $-1.3M | $-7.0M | $-10.8M | $-10.3M | $-6.4M | ||
| EBITDA | $1.2M | $1.4M | $-446.2K | $1.5M | $1.0M | $1.6M | $-6.6M | $-10.2M | $-8.9M | $-5.2M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $4.5K | $3.4K | $1.9K | -- | $-239 | $237 | $60 | $5.4K | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $2.9K | $-3.4K | $-1.9K | -- | $239 | $-237 | $-60 | $-145.6K | $-25.3K | $-21.9K | ||
| Other Income/Expense | -- | $9.2K | $-2.9K | $-33.0K | $-128.5K | $-59.0K | $-694.0K | $-39.9K | $-501.5K | $-428.5K | ||
| Other Special Charges | -- | $-9.2K | $2.9K | $28.1K | $80.7K | $42.4K | $693.0K | $145.6K | $561.3K | $444.6K | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | -- | -- | -- | $-899.0K | $-3.4M | $-2.4M | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $1.0M | $1.1M | $-774.8K | $1.2M | $696.2K | $1.2M | $-7.0M | $-10.8M | $-9.8M | $-6.1M | ||
| Pre-Tax Income | $1.0M | $1.1M | $-776.7K | $1.2M | $696.4K | $1.2M | $-6.4M | $-10.7M | $-9.8M | $-6.1M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $307.0K | $359.7K | $-241.7K | $266.4K | $132.1K | $-17.8K | $-1.8M | $-2.0M | $4.0M | $2.9K | ||
| NET INCOME | ||||||||||||
| Net Income | $703.4K | $782.9K | $-535.0K | $910.6K | $564.3K | $-1.2M | $-4.6M | $-8.7M | $-13.7M | $-6.1M | ||
| Net Income (Continuing Operations) | $703.4K | $782.9K | $-535.0K | $910.6K | $564.3K | $-1.2M | $-4.6M | $-8.7M | $-13.7M | $-6.1M | ||
| Net Income (Discontinued Operations) | $703.4K | $782.9K | $-535.0K | $910.6K | $564.3K | $-1.2M | $-4.6M | $-8.7M | $-13.7M | $-6.1M | ||
| Net Income (Common Stockholders) | $703.4K | $782.9K | $-535.0K | $910.6K | $564.3K | $-1.2M | $-4.6M | $-8.7M | $-13.7M | $-6.1M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-8.2M | -- | -- | -- | ||
| TOTALS | ||||||||||||
| Total Expenses | $-7.7M | $-11.1M | $-13.0M | $-16.2M | $-22.6M | $25.4M | $30.5M | $38.7M | $38.8M | $40.1M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $36.7M | $38.0M | $37.8M | $38.1M | $38.8M | $41.9M | $44.4M | $45.0M | $45.6M | $45.8M | ||
| Average Shares Outstanding (Diluted) | $36.7M | $38.0M | $37.9M | $38.9M | $39.1M | $41.9M | $44.4M | $45.0M | $45.6M | $45.8M | ||
| Shares Outstanding | $36.7M | $38.0M | $37.8M | $38.2M | $39.7M | $44.5M | $44.7M | $45.5M | $45.7M | $46.2M | ||
| Basic EPS | $0.02 | $0.02 | $-0.01 | $0.02 | $0.01 | $-0.03 | $-0.10 | $-0.19 | $-0.30 | $-0.13 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-0.03 | $-0.10 | $-0.19 | $-0.30 | $-0.13 | ||
| Diluted EPS | $0.02 | $0.02 | $-0.01 | $0.02 | $0.01 | $-0.03 | $-0.10 | $-0.19 | $-0.30 | $-0.13 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-0.03 | $-0.10 | $-0.19 | $-0.30 | $-0.13 | ||
| OTHER METRICS | ||||||||||||
| Gain On Sale Of P P E | -- | -- | -- | $4.9K | $47.8K | $16.6K | $1.0K | -- | $-59.8K | $-16.2K | ||
| Non Recurring Operation Expense | -- | -- | -- | $899.0K | $3.4M | $2.4M | -- | -- | -- | -- | ||
| Other Gand A | -- | $-132.5K | $-132.5K | $-132.5K | $-171.0K | $12.0M | $17.9M | $20.6M | $20.4M | $21.6M | ||
| Rent And Landing Fees | -- | $-132.5K | $-132.5K | $-132.5K | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $3.9M | $5.9M | $7.8M | $8.2M | $9.8M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KRMD | $3.96 | +1.5% | 69.28K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get KORU Medical Systems Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW